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Text: 
Guidelines in the UK recommend that children and young people living with Type 1 DM and Type 2 DM 
undergo annual screening for diabetic retinopathy from the age of 12 years.[1] This is currently 
delivered though a large number of regional diabetic eye screening programmes (DESPs) which are 
responsible for identifying eligible children and young people and inviting them to a screening 
appointment (Fig. 1). In 2014/2015 the National Paediatric Diabetes Audit, based on secondary 
(hospital-based) care data for over 27,600 children, revealed that only 64% of eligible English children 
and young people had been recorded as having undergone diabetic retinopathy screening during the 
last audit year, of whom, 13% were reported to have at least background diabetic retinopathy.[2] One 
potential cause of low screening coverage is incomplete ascertainment of the eligible population. There 
has been no systematic investigation of how this population is identified in the English DESPs.  
Through multi-disciplinary collaborative clinical research network—the Diabetic Eye disease in 
Childhood Study (DECS) group – we are undertaking a multi-faceted research programme to address the 
current paucity of information about the frequency and natural history of childhood diabetic eye 
disease, in order to inform service planning including diabetic eye screening. From this programme we 
report here a survey (both postal and electronic approaches) of the 70 English DESPs which was 
conducted between October 2015 and February 2016. In the absence of a centralised register, contact 
details of programme leads were manually identified through multiple sources, and at least two 
reminders were sent to non-responding DESPs. 
Questionnaires were received from 42 programmes (response rate = 60%). All programmes used 
primary care (family practitioner) registration systems to compile their screening lists. Eighteen (43%) 
also drew on information from hospital diabetes clinics (secondary care) as a complementary source.  
Less than a third of programmes (n=13) actively searched for eligible patients not registered with a 
family practitioner, group classified as hard to reach by the DESPs. 52% (n=22) included patients with 
“syndromatic”/secondary diabetes such as Wolfram Syndrome. In 19% (n=8) of programmes, screening 
lists were generated entirely manually e.g. using referral letters from family practitioners, and in 24% 
(n=10) combined manual and electronic methods were used. Frequency of list update varied, from daily 
to 6 monthly. Information about attendance at Hospital Eye Services following referral for an abnormal 
screening result was routinely fedback to 93% (n=39) of DESPs.  
We report significant heterogeneity and some potential vulnerabilities in the means by which children 
and young people eligible for diabetic retinopathy screening are identified by DESPs. This may be a risk 
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to complete screening coverage in this population.  Differences in methods of ascertainment of children 
and young people living with diabetes might explain in part the high regional heterogeneity in diabetic 
retinopathy screening coverage reported by the National Paediatric Diabetes Audit 2014/2015, which 
ranges from 0% to 100% (median: 77%; interquartile range: 58-91%).[2] Since children and young people 
living with diabetes are largely diagnosed and managed in secondary care, we suggest it is crucial that 
both secondary and primary care patient information/registration systems are used to identify this 
population.  
Whilst treatment-requiring paediatric diabetic retinopathy is thought to be uncommon,[3] abnormal 
retinal vascular findings are present in 6% and 24% of 12 and 18 year olds respectively,[2] and may be 
the first indicator of microvascular disease.[4] Although there is limited understanding of the natural 
history of diabetic retinopathy in children and young people, in particular the outcome of the abnormal 
retinal findings, it is well-recognised that vasculopathy is the main cause of the increased mortality seen 
in individuals diagnosed with T1 DM in childhood.[5] This, along with the projected doubling European 
incidence of Type 1 DM between 2005-2020,[6] and the rising incidence of paediatric Type 2 DM,[7] calls 
for collaborative efforts to increase the diabetic retinopathy screening uptake, ensure integrated 
paediatric diabetes care, and increase our understanding of paediatric diabetic retinopathy. Other 
aspects of DECS should provide evidence to support these developments so as to reduce the risk of 
preventable visual loss and vascular complications in early adulthood. 
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Figure 1. Points of care of children and young people living with diabetes.  
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Paediatric Diabetes Units 
(Secondary hospital care) 
DM diagnosis confirmation, 
registration, monitoring 
complications, and providing data 
for the national audit. 
Hospital Eye Services (HES) 
(Tertiary care) 
Conducting diabetic eye screening in selected cases, diagnosis 
confirmation and treatment of referred cases from DESPs. 
Family Practitioners  
(Primary care)  
Referral of CYP the DESPs at 12 years old. 
Diabetic Eye Screening 
programmes (DESPs, n=70) 
Identification eligible population 
and invitation to diabetic eye 
screening. Referral cases of sight-
threatening retinopathy to HES. 
Page 7 of 9 Diabetic Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Diabetic Eye Disease in Childhood Study (DECS) group 
Dr S. Althauser, Royal Free Hospital, London; Dr J. Anderson, St Bartholomew's Hospital, 
London; Ms J. Ashworth, Manchester Royal Eye Hospital, Manchester; Dr P. Bhattacharyya, 
Royal Preston Hospital, Lancashire; Mr S. Biswas, Manchester Royal Eye Hospital, Manchester; 
Mr C. Brand, Royal Hallamshire Hospital, Sheffield; Dr D. Broadbent, Royal Liverpool University 
Hospital, Liverpool; Mr A. Brown, Royal Stoke University Hospital, Staffordshire; Mr B. Burton, 
James Paget University Hospital, Norfolk; Mr A. Chandna, Alder Hey Children's Hospital, 
Liverpool; Mr H C. Chen, Royal Derby Hospital, Derby; Mr V. Chong, Oxford Eye Hospital, 
Oxford; Mr S. Choudhary, Chesterfield Royal Hospital, Chesterfield; Dr H. Cilliers, Warwick 
Hospital, Warwick; Dr M. Clarke, Heartlands Hospital, Birmingham; Ms A. Cole, Bristol Eye 
Hospital, Bristol; Dr H. Cook, Hull Royal Infirmary, Hull; Dr T. Criddle, Royal Liverpool University 
Hospital, Liverpool; Mr T. Dabbs, Leeds Teaching Hospitals, Leeds; Mr N. Davies, Chelsea and 
Westminster Hospital, London; Mr J. Deane, Leicester Royal Infirmary, Leicester; Dr S. Dhanoa, 
Milton Keynes University Hospital, Milton Keynes; Professor B. Dhillon, University of Edinburgh, 
Edinburgh; Mr N. Dhingra, Pinderfields Hospital, Wakefield; Ms L. Dhir, Chelsea and 
Westminster Hospital, London; Dr T. Dugal, Royal Cornwall Hospital, Cornwall; Mr M. Eckstein, 
Brighton and Sussex University Hospitals, Brighton; Ms C. Egan, Moorfields Eye Hospital, 
London; Mr H. Eleftheriadis, King’s College Hospital, London; Mr I.A. El-Ghrably, James Cook 
University Hospital, Middlesbrough; Mr D. Flanagan, Moorfields Eye Hospital, London; 
Professor B. Fleck, Royal Hospital for Sick Children, Edinburgh; Dr A. Gaskell, Ayr Hospital, Ayr; 
Dr T. Gazis, Nottingham City Hospital, Nottingham; Ms S. George, Hillingdon Hospital, Uxbridge; 
Professor F. Ghanchi, Bradford Ophthalmology Research Network, Bradford; Mr C. Goldsmith, 
James Paget University Hospital, Norfolk; Ms P. Gordon-Bennett, Western Sussex Hospitals NHS 
Foundation Trust, Sussex; Mr S. Harsum, Epsom and St Helier University Hospitals NHS Trust, 
Surrey; Mr T. Hashmi, The Pennine Acute Hospitals NHS Trust, Nottingham; Dr J P. Hosker, 
Doncaster Royal Infirmary, Doncaster; Ms H. Jackson, West Kent Eye Centre, Kent; Dr S. 
Janikoun, Guy's and St Thomas' NHS Foundation Trust, London; Dr L. Johnson,  Gloucestershire 
Royal NHSFT, Gloucester; Mr R. Johnston, Cheltenham General Hospital, Gloucestershire; Mr C. 
Jones, Norfolk and Norwich University Hospital, Norwich; Mrs R. Khan, Calderdale & 
Huddersfield NHS Trust, West Yorkshire; Mr I. Khan, Hillingdon Hospital, Uxbridge; Ms R. 
Krishnan, Southampton General Hospital, Southampton; Mrs A. Kulkarni, Warwick Hospital, 
Warwick; Mr B V. Kumar, Wirral University Hospital NHS Trust, Wirral; Professor G. Leese, 
Ninewells Hospital and Medical School, Dundee; Mr T. Leong,  Worthing Hospital, West Sussex; 
Mr A. Lobo, Bedford Hospital, Bedford; Mr V. Long, St. James's University Hospital, Leeds; Dr A. 
MacLeod, Royal Shrewsbury Hospital, Shrewsbury; Dr M. MacRae, Princess Alexandra Eye 
Pavilion, Edinburgh; Mrs S. Mann, St Thomas’ Hospital, London; Mr R.H.C. Markham, Bristol Eye 
Hospital, Bristol; Mr M. McKibbin, St James University Hospital, Leeds; Ms S. Meredith, Queen 
Alexandra Hospital, Portsmouth; Mr S. Mithra, Queen Elizabeth II Hospital, Hertfordshire; Dr A. 
Mulvihill, Princess Alexandra Eye Pavilion, Edinburgh; Dr D. Nagi, Mid Yorkshire Hospitals NHS 
Trust, West Yorkshire; Mr S. Natha, Wrightington, Wigan and Leigh NHS Foundation Trust, 
Wigan; Mr H. Nayak, Alder Hey Children's Hospital, Liverpool; Mr W.D. Newman, Manchester 
Page 8 of 9Diabetic Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Royal Eye Hospital, Manchester; Dr M. Ng, Southport and Ormskirk NHS Trust, Ormksirk; Ms Z. 
Ockrim, Moorfields Eye Hospital, London; Dr J.A. Olson, Aberdeen Royal Infirmary, Aberdeen; 
Mrs O. Osoba, Torbay Hospital, Torquay; Professor D.R. Owens, Diabetes Research Group, 
Swansea University, Swansea; Mr J. Patil, Furness General Hospital, Barrow-in-Furness; Dr T. 
Peto, Moorfields Eye Hospital, London; Dr R. Pilling, Bradford Teaching Hospitals NHS 
Foundation Trust, Bradford; Professor S.M. Rajbhandari, Lancashire Teaching Hospital, 
Lancashire; Mrs C. Rennie, Southampton General Hospital, Southampton; Mr T. Robinson, Royal 
United Hospitals Bath NHS Foundation Trust, Bath; Ms C. Sanghvi, East Lancashire Hospitals 
NHS Trust, Burnley; Mr J. Sardar, Shrewsbury and Telford NHS Trust, Shropshire; Dr S. Sen, 
Warrington Hospital, Warrington; Ms R. Setty, Bradford Teaching Hospitals NHS Foundation 
Trust, Bradford; Mr V. Sharma, Manchester Royal Eye Hospital, Manchester; Ms S. Sivaprasad, 
Moorfields Eye Hospital, London; Mr R. Smith, Buckinghamshire Healthcare NHS Trust, 
Buckinghamshire; Mr D. Steel, Sunderland Eye Infirmary, Sunderland; Mrs I.M. Stratton, 
Gloucestershire Retinal Research Group, Cheltenham; Dr C. Styles, Queen Margaret Hospital, 
Fife; Dr M.I. Tahir, Prince Charles Eye Unit, KE VII Hospital, Windsor; Ms G. Vafidis, Central 
Middlesex Hospital, London; Ms D. Vaideanu-Collins, James Cook University Hospital, 
Middlesbrough; Dr J. Warner, University Hospital of Wales, Cardiff; Dr G. Watts, Royal Bolton 
Hospital, Lancashire; Mr N. Wilson-Holt, Royal Cornwall Hospitals NHS Trust, Cornwall; Mr W. 
Wykes, NHS Greater Glasgow and Clyde, Glasgow; Dr B. Young, Salford Royal Hospital, Salford. 
 
 
Page 9 of 9 Diabetic Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
